Senestech (SNES) Registration Filing summary

Company overview and business model

• Develops and commercializes fertility control products for managing animal pest populations, focusing on rats.

• Main products are ContraPest (liquid bait) and Evolve (soft bait), both targeting reproductive systems of rats.

• ContraPest is EPA-registered and available in all 50 states; Evolve is exempt from EPA registration and authorized in 30 states.

• Holds a portfolio of international patents for product compounds and delivery methods, with protection extending to at least 2033.

Financial performance and metrics

• Has incurred operating losses since inception and expects continued significant expenses and losses for the foreseeable future.

• Financial statements as of December 31, 2023, prepared under the assumption of going concern, with substantial doubt expressed by auditors.

• Received approximately $2.3 million in gross proceeds from warrant exercises in August 2024.

Use of proceeds and capital allocation

• Will not receive proceeds from resale of shares by selling stockholders, except for cash received from warrant exercises.

• Proceeds from warrant exercises will be used for general corporate purposes, including R&D, capital expenditures, working capital, administrative expenses, and potential acquisitions or investments.